Metraipolis › archive › dc_84c11bb186d2
Potential hidden Plasmodium vivax malaria reservoirs from low parasitemia Duffy-negative Ethiopians: Molecular evidence — Europe PMC PMID:37399221
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/37399221
- DOI
- 10.1371/journal.pntd.0011326
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-07T12:58:59.396Z
- SHA-256 of the archived text
e7f11630b478cecb9056865a4ee2b1582a0a22b37926e3ff02230f25df434a63- Stable URL of this page
https://metraipolis.com/documento/dc_84c11bb186d2
How to cite
Potential hidden Plasmodium vivax malaria reservoirs from low parasitemia Duffy-negative Ethiopians: Molecular evidence — Europe PMC PMID:37399221 — Europe PMC (en), https://europepmc.org/article/MED/37399221 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_84c11bb186d2 (Metraipolis archive dc_84c11bb186d2, sha256 e7f11630b478cecb9056865a4ee2b1582a0a22b37926e3ff02230f25df434a63)
BibTeX
@misc{dc84c11bb186d2,
title = {Potential hidden Plasmodium vivax malaria reservoirs from low parasitemia Duffy-negative Ethiopians: Molecular evidence — Europe PMC PMID:37399221},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/37399221},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_84c11bb186d2; sha256 e7f11630b478cecb9056865a4ee2b1582a0a22b37926e3ff02230f25df434a63},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37399221. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Background: The interaction between the Plasmodium vivax Duffy-binding protein and the corresponding Duffy Antigen Receptor for Chemokines (DARC) is primarily responsible for the invasion of reticulocytes by P. vivax. The Duffy-negative host phenotype, highly prevalent in sub-Saharan Africa, is caused by a single point mutation in the GATA-1 transcription factor binding site of the DARC gene promoter. The aim of this study was to assess the Duffy status of patients with P. vivax infection from different study sites in Ethiopia. Methods: A cross-sectional study was conducted from February 2021 to September 2022 at five varying eco-epidemiological malaria endemic sites in Ethiopia. Outpatients who were diagnosed with P. vivax infection (pure and mixed P. vivax/P. falciparum) by microscopy and Rapid Diagnostic Test (RDT) were subjected to PCR genotyping at the DARC promoter. The associations between P. vivax infection, host genotypes and other factors were evaluated. Result: In total, 361 patients with P. vivax infection were included in the study. Patients with pure P. vivax infections accounted for 89.8% (324/361), while the remaining 10.2% (37/361) had mixed P. vivax/P. falciparum infections. About 95.6% (345/361) of the participants were Duffy-positives (21.2% homozygous and 78.8%, heterozygous) and 4.4% (16/361) were Duffy-negatives. The mean asexual parasite density in homozygous and heterozygous Duffy-positives was 12,165 p/μl (IQR25-75: 1,640-24,234 p/μl) and11,655 p/μl (IQR25-75: 1,676-14,065 p/μl), respectively, significantly higher than that in Duffy-negatives (1,227p/μl; IQR25-75: 539-1,732p/μl). Conclusion: This study confirms that Duffy-negativity does not provide complete protection against P. vivax infection. The development of P. vivax-specific elimination strategies, including alternative antimalarial vaccines should be facilitated by a better understanding of the epidemiological landscape of vivax malaria in Africa. More importantly, low parasitemia associated with P. vivax infections in Duffy-negative patients may represent hidden reservoirs of transmission in Ethiopia. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS neglected tropical diseases, 2023 (prima pubblicazione 2023-07-03). Identificativi: PMID 37399221 · PMCID PMC10348516 · DOI 10.1371/journal.pntd.0011326. Descrittori MeSH principali: Malaria, Vivax; Duffy Blood-Group System. Pagina: https://europepmc.org/article/MED/37399221 — https://doi.org/10.1371/journal.pntd.0011326. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-07T12:29:41.754Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.